{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:20:36Z","timestamp":1793172036828,"version":"4.5.0"},"reference-count":84,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001851","name":"Ministry of Earth Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019126","name":"Gujarat Council on Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018941","name":"Indian Institute of Technology Gandhinagar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gujarat State Biotechnology Mission, Department of Science and Technology, Government of Gujarat","id":[{"id":"https:\/\/ror.org\/035dsh769","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>While nucleotide\u2013peptide conjugates and peptide\u2013drug conjugates demonstrate a considerable evolution as next-generation therapeutics, the successful translation of these complex agents relies on advances in bioconjugation strategies. By anchoring nucleotides or pharmaceutical payloads to multifaceted peptide scaffolds, researchers have engineered molecular platforms with dual mechanisms of action. However, to fully realize the potential of these hybrid systems, further refinements are required to ensure both in vivo stability and retention of the desired biological activities over time. This comprehensive review examines ongoing progress toward optimizing conjugation chemistry for the development of stable and efficacious NPC and PDC candidates. Through evaluation of fundamental design principles and their clinical relevance, it aims to accelerate the journey of these multilayered biomolecular constructs from theory to practice. It details various strategies to mitigate challenges such as enzymatic degradation and rapid systemic clearance, including covalent linkages (e.g., aminoacylation and thiol oxidation) and noncovalent interactions (e.g., ligand\u2013receptor binding). Central to this emerging field is the integration of artificial intelligence and deep learning, which are rapidly transforming the design and development of NPCs and PDCs. AI-driven tools enable predictive modeling of peptide\u2013drug interactions, intelligent linker optimization, and in silico screening of bioactive scaffolds\u2014thus redefining the pipeline for precision therapeutics with improved selectivity and translatability. The potential of hybrid nanostructures formed by peptide\u2013DNA conjugates for advanced drug delivery and diagnostic applications is also discussed. Furthermore, the clinical translation of PDCs demonstrates their promise in treating conditions such as cancer, neurodegenerative diseases, and inflammatory disorders, alongside the ongoing challenges regarding peptide availability, linker optimization, and scalable synthesis. The review concludes by discussing future directions of NPCs and PDCs, highlighting the role of interdisciplinary approaches in advancing precision medicine and addressing complex therapeutic needs.<\/jats:p>","DOI":"10.1021\/acsbiomaterials.6c00187","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:09:23Z","timestamp":1780416563000},"page":"3249-3266","source":"Crossref","is-referenced-by-count":3,"title":["AI-Driven Design and Clinical Translation of Nucleotide\u2212Peptide and Peptide\u2212Drug Conjugates"],"prefix":"10.1021","volume":"12","author":[{"given":"Kshipra","family":"Pandey","sequence":"first","affiliation":[{"name":"Indrashil University , , Kadi , , ,","place":["Mehsana, Gujarat, India, 382715"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Dave","sequence":"additional","affiliation":[{"name":"Indrashil University , , Kadi , , ,","place":["Mehsana, Gujarat, India, 382715"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Patel","sequence":"additional","affiliation":[{"name":"Indrashil University , , Kadi , , ,","place":["Mehsana, Gujarat, India, 382715"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-8109","authenticated-orcid":true,"given":"Sandeep","family":"Verma","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Kanpur , , ,","place":["Kanpur, India, 208016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-9961","authenticated-orcid":true,"given":"Raghu","family":"Solanki","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Gandhinagar , , , ,","place":["Palaj, Gujarat, India, 382355"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-3746","authenticated-orcid":true,"given":"Amit","family":"Yadav","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Gandhinagar , , , ,","place":["Palaj, Gujarat, India, 382355"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2479-2113","authenticated-orcid":true,"given":"Nidhi","family":"Gour","sequence":"additional","affiliation":[{"name":"Indrashil University , , Kadi , , ,","place":["Mehsana, Gujarat, India, 382715"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1478-6417","authenticated-orcid":true,"given":"Dhiraj","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Gandhinagar , , , ,","place":["Palaj, Gujarat, India, 382355"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"11","key":"2026101319072593500_cit1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115131","article-title":"Therapeutic peptides: recent advances in discovery, synthesis, and clinical translation","volume":"26","author":"Zheng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026101319072593500_cit2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"2026101319072593500_cit3","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1021\/acs.jmedchem.3c01835","article-title":"Peptide\u2212drug conjugates: An emerging direction for the next generation of peptide therapeutics","volume":"67","author":"Dean","year":"2024","journal-title":"J. Med. Chem."},{"issue":"15","key":"2026101319072593500_cit4","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1200\/JCO.2018.36.15_suppl.5503","article-title":"ZoptEC: Phase III randomized controlled study comparing zoptarelin with doxorubicin as second line therapy for locally advanced, recurrent, or metastatic endometrial cancer (NCT01767155)","volume":"36","author":"Miller","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"2026101319072593500_cit5","doi-asserted-by":"crossref","DOI":"10.31525\/fda1-ucm594105.htm","volume-title":"FDA approves lutetium Lu 177 dotatate for treatment of GEP-NETS","author":"US Food and Drug Administration","year":"2018"},{"key":"2026101319072593500_cit6","doi-asserted-by":"publisher","first-page":"v174","DOI":"10.1093\/annonc\/mdz244.026","article-title":"Pharmacokinetic (PK) assessment of BT1718: A phase I\/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours","volume":"30","author":"Cook","year":"2019","journal-title":"Ann. Oncol."},{"issue":"23","key":"2026101319072593500_cit7","doi-asserted-by":"publisher","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","article-title":"AI-driven drug discovery: a comprehensive review","volume":"10","author":"Ferreira","year":"2025","journal-title":"ACS Omega"},{"issue":"3","key":"2026101319072593500_cit8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1039\/D5CC04998A","article-title":"Peptide-based drug design using generative AI","volume":"62","author":"Ekambaram","year":"2026","journal-title":"Chem. Commun."},{"issue":"8","key":"2026101319072593500_cit9","doi-asserted-by":"publisher","DOI":"10.1002\/psc.70040","article-title":"Peptide-Drug Conjugates: A New Hope for Cancer","volume":"31","author":"Armstrong","year":"2025","journal-title":"J. Pept. Sci."},{"issue":"4","key":"2026101319072593500_cit10","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"6","key":"2026101319072593500_cit11","doi-asserted-by":"publisher","DOI":"10.3390\/genes14061194","article-title":"Peptides of a feather: How computation Is taking peptide therapeutics under its wing","volume":"14","author":"Kazmirchuk","year":"2023","journal-title":"Genes"},{"issue":"6","key":"2026101319072593500_cit12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29061405","article-title":"Composite of KLVFF-Transthyretin-Penetratin and Manganese Dioxide Nanoclusters: A Multifunctional Agent against Alzheimer\u2019s \u03b2-Amyloid Fibrillogenesis","volume":"29","author":"Lan","year":"2024","journal-title":"Molecules"},{"issue":"4","key":"2026101319072593500_cit13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"2026101319072593500_cit14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discovery Today"},{"issue":"5","key":"2026101319072593500_cit15","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202200580","article-title":"Designer, Programmable DNA-peptide hybrid materials with emergent properties to probe and modulate biological systems","volume":"24","author":"Menon","year":"2023","journal-title":"Chembiochem"},{"issue":"2","key":"2026101319072593500_cit16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.apsb.2022.07.020","article-title":"Peptide\u2212drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?","volume":"13","author":"Fu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"2026101319072593500_cit17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/nejmoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026101319072593500_cit18","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae186","article-title":"Phase II trial of blood\u2212brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma","volume":"6","author":"Dmello","year":"2024","journal-title":"Neuro. Oncol. Adv."},{"issue":"4","key":"2026101319072593500_cit19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1042\/BST0350775","article-title":"Cell-penetrating-peptide-based delivery of oligonucleotides: an overview","volume":"35","author":"Abes","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"2026101319072593500_cit20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.687926","article-title":"Linker design impacts antibody-drug conjugate pharmacokinetics and efficacy via modulating the stability and payload release efficiency","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"2026101319072593500_cit21","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S1470-2045(16)30030-4","article-title":"Antibody\u2212drug conjugates for cancer therapy","volume":"17","author":"Thomas","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1-2","key":"2026101319072593500_cit22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discovery Today"},{"issue":"5","key":"2026101319072593500_cit23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/anie.201204631","article-title":"Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries","volume":"52","author":"Krall","year":"2013","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"2026101319072593500_cit24","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbad018","article-title":"LAVAA: a lightweight association viewer across ailments","volume":"3","author":"Fauman","year":"2023","journal-title":"Bioinformatics Adv."},{"issue":"7873","key":"2026101319072593500_cit25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"2026101319072593500_cit26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide\u2212drug conjugates as effective prodrug strategies for targeted delivery","volume":"110","author":"Wang","year":"2017","journal-title":"Adv. Drug Delivery Rev."},{"issue":"4","key":"2026101319072593500_cit27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab."},{"issue":"11","key":"2026101319072593500_cit28","doi-asserted-by":"publisher","first-page":"13148","DOI":"10.3390\/molecules181113148","article-title":"Peptide conjugation via CuAAC \u2018click\u2019chemistry","volume":"18","author":"Ahmad Fuaad","year":"2013","journal-title":"Molecules"},{"issue":"4-5","key":"2026101319072593500_cit29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"2026101319072593500_cit30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1359-6446(00)01594-4","article-title":"Folate-mediated targeting: from diagnostics to drug and gene delivery","volume":"6","author":"Leamon","year":"2001","journal-title":"Drug Discovery Today"},{"issue":"2","key":"2026101319072593500_cit31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","article-title":"The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"2026101319072593500_cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2024.102552","article-title":"Advances in acid-degradable and enzyme-cleavable linkers for drug delivery","volume":"84","author":"Zhao","year":"2025","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8-9","key":"2026101319072593500_cit33","doi-asserted-by":"publisher","DOI":"10.1002\/ijch.202300174","article-title":"Expanding the Scope of Ribosome-Mediated Biosynthesis in vitro using tRNA-Aminoacylating Ribozyme","volume":"64","author":"Cho","year":"2024","journal-title":"Isr. J. Chem."},{"issue":"35","key":"2026101319072593500_cit34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2410206121","article-title":"A potential role for RNA aminoacylation prior to its role in peptide synthesis","volume":"121","author":"Radakovic","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"2026101319072593500_cit35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cbpa.2007.08.011","article-title":"The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus","volume":"11","author":"Ohuchi","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"2026101319072593500_cit36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","article-title":"Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities","volume":"55","author":"Saito","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2026101319072593500_cit37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1142\/9789814616928_0002","article-title":"Redox-Sensitive Polymeric Nanoparticles for Intracellular Drug Delivery","author":"Wen","year":"2015","journal-title":"Bio-Inspired Nanomaterials and Applications: Nano Detection, Drug\/Gene Delivery, Medical Diagnosis and Therapy"},{"issue":"11","key":"2026101319072593500_cit38","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11%3C2004::AID-ANIE2004%3E3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem., Int. Ed."},{"issue":"4","key":"2026101319072593500_cit39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1039\/b901970g","article-title":"Cu-free click cycloaddition reactions in chemical biology","volume":"39","author":"Jewett","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"16","key":"2026101319072593500_cit40","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2174\/1381612811319160009","article-title":"Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy","volume":"19","author":"Betts","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"2026101319072593500_cit41","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1021\/ja100014q","article-title":"Rapid Cu-free click chemistry with readily synthesized biarylazacyclooctynones","volume":"132","author":"Jewett","year":"2010","journal-title":"J. Am. Aud. Soc."},{"issue":"5","key":"2026101319072593500_cit42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054590","article-title":"A novel homodimer peptide\u2212drug conjugate improves the efficacy of HER2-positive breast cancer therapy","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026101319072593500_cit43","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/s41467-024-47188-6","article-title":"An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"key":"2026101319072593500_cit44","doi-asserted-by":"publisher","DOI":"10.22541\/au.168880328.86579379\/v1","article-title":"Stimuli-responsive linkers and their application in molecular imaging","author":"Wang","year":"2023"},{"issue":"10","key":"2026101319072593500_cit45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/nbt.2968","article-title":"Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates","volume":"32","author":"Lyon","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"2026101319072593500_cit46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody\u2212drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"8","key":"2026101319072593500_cit47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"14","key":"2026101319072593500_cit48","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"2026101319072593500_cit49","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/ph17111556","article-title":"Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine\u2212Glycine\u2212Aspartate) Strategies","volume":"17","author":"Bogdanovi\u0107","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"11","key":"2026101319072593500_cit50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"27","key":"2026101319072593500_cit51","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202470170","article-title":"Multifaceted Hydrogel Scaffolds: Bridging the Gap between Biomedical Needs and Environmental Sustainability (Adv. Healthcare Mater 27\/2024)","volume":"13","author":"Mamidi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"13","key":"2026101319072593500_cit52","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1039\/D4NR05298F","article-title":"Advanced disease therapeutics using engineered living drug delivery systems","volume":"17","author":"Mamidi","year":"2025","journal-title":"Nanoscale"},{"key":"2026101319072593500_cit53","volume-title":"177Lu-DOTA0-Tyr3-Octreotate (Lutathera\u00ae) compared to Octreotide LAR in patients with inoperable progressive, somatostatin receptor positive, midgut carcinoid tumours (NETTER-1) (NCT01578239)","author":"ClinicalTrials.gov","year":"2012"},{"issue":"6","key":"2026101319072593500_cit54","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1158\/1078-0432.CCR-12-2481","article-title":"Phase I study of GRN1005 in recurrent malignant glioma","volume":"19","author":"Drappatz","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"2026101319072593500_cit55","volume-title":"ANG1005 in patients with recurrent glioblastoma multiforme (GBM) (NCT02048059)","author":"ClinicalTrials.gov","year":"2014"},{"issue":"2","key":"2026101319072593500_cit56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/IGC.0000000000000044","article-title":"Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5)","volume":"24","author":"Emons","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"12","key":"2026101319072593500_cit57","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2212PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026101319072593500_cit58","volume-title":"VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) (NCT03511664)","author":"ClinicalTrials.gov","year":"2018"},{"key":"2026101319072593500_cit59","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.54","article-title":"Dual myostatin and dystrophin exon skipping by morpholino nucleic acid oligomers conjugated to a cell-penetrating peptide is a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy","volume":"1","author":"Malerba","year":"2012","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"10","key":"2026101319072593500_cit60","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s1470-2045(17)30517-x","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"2026101319072593500_cit61","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7362","article-title":"DeepBindRG: a deep learning based method for estimating effective protein\u2212ligand affinity","volume":"7","author":"Zhang","year":"2019","journal-title":"PeerJ"},{"issue":"1","key":"2026101319072593500_cit62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319483121","article-title":"Trojan horse peptide conjugates remodel the activity spectrum of clinical antibiotics","volume":"122","author":"Luo","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"2026101319072593500_cit63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41592-023-02086-5","article-title":"Accurate prediction of protein\u2212nucleic acid complexes using RoseTTAFoldNA","volume":"21","author":"Baek","year":"2024","journal-title":"Nat. Methods"},{"key":"2026101319072593500_cit64","doi-asserted-by":"publisher","first-page":"20295","DOI":"10.1021\/acsnano.5c00670","article-title":"Using Machine Learning to Fast-Track Peptide Nanomaterial Discovery","author":"Dra\u017ei\u0107","year":"2025","journal-title":"ACS. Nano"},{"issue":"1","key":"2026101319072593500_cit65","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41467-023-38056-w","article-title":"Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery","volume":"14","author":"Hsueh","year":"2023","journal-title":"Nat. Commun."},{"key":"2026101319072593500_cit66","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41586-024-08435-4","article-title":"Targeting protein\u2212ligand neosurfaces with a generalizable deep learning tool","author":"Marchand","year":"2025","journal-title":"Nature"},{"key":"2026101319072593500_cit67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41586-024-08070-z","article-title":"Machine-guided design of cell-type-targeting cis-regulatory elements","author":"Gosai","year":"2024","journal-title":"Nature"},{"issue":"13","key":"2026101319072593500_cit68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv1971","article-title":"Learning the rules of peptide self-assembly through data mining with large language models","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"key":"2026101319072593500_cit69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1553853","article-title":"Trends in the research and development of peptide drug conjugates: artificial intelligence aided design","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"9","key":"2026101319072593500_cit70","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1021\/cr0502448","article-title":"Peptide conjugates of oligonucleotides: synthesis and applications","volume":"106","author":"Venkatesan","year":"2006","journal-title":"Chem. Rev."},{"issue":"1","key":"2026101319072593500_cit71","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/pharmaceutics17010109","article-title":"Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"issue":"5","key":"2026101319072593500_cit72","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1039\/D0TB02168G","article-title":"Recent advances in co-delivery nanosystems for synergistic action in cancer treatment","volume":"9","author":"Carvalho","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"7","key":"2026101319072593500_cit73","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1200\/JCO.20.02259","article-title":"Melflufen and dexamethasone in heavily pretreated relapsed and refractory multiple myeloma","volume":"39","author":"Richardson","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"2026101319072593500_cit74","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026101319072593500_cit75","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106285","article-title":"Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce \u03b1-synuclein in a mouse model of Alzheimer's disease","volume":"186","author":"Leit\u00e3o","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"2026101319072593500_cit76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jconrel.2024.02.040","article-title":"Peptide targeting improves the delivery and therapeutic index of glucocorticoids to treat rheumatoid arthritis","volume":"368","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"2026101319072593500_cit77","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101428","article-title":"Functionalizing dendrimers for targeted delivery of bioactive molecules to macrophages: A potential treatment for mycobacterium tuberculosis infection\u2014A review","volume":"16","author":"Sanhueza","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"17","key":"2026101319072593500_cit78","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.3390\/molecules26175420","article-title":"Chemistry of peptide-oligonucleotide conjugates: a review","volume":"26","author":"Klabenkova","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"2026101319072593500_cit79","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/2168479015592195","article-title":"Oligonucleotide-based drug development: considerations for clinical pharmacology and immunogenicity","volume":"49","author":"Wang","year":"2015","journal-title":"Ther. Innov. Regul. Sci"},{"key":"2026101319072593500_cit80","volume-title":"FDA Briefing Document: Oncopeptides AB, NDA 214383, melflufen","author":"U.S. Food and Drug Administration","year":"2021"},{"issue":"15","key":"2026101319072593500_cit81","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1039\/D4NA00145A","article-title":"Revolutionizing cancer therapy using tetrahedral DNA nanostructures as intelligent drug delivery systems","volume":"6","author":"Sharma","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"7","key":"2026101319072593500_cit82","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.7150\/thno.43298","article-title":"Allele-specific genome targeting in the development of precision medicine","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"2026101319072593500_cit83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobme.2026.100659","article-title":"Editorial Overview on \u201cNanobiomaterials Advances\u201d","author":"Mamidi","year":"2026","journal-title":"Curr. Opin. Biomed. Eng."},{"issue":"34","key":"2026101319072593500_cit84","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1039\/D5TB01133G","article-title":"Advances in three-dimensional hydrogel networks for cancer immunotherapy","volume":"13","author":"Mamidi","year":"2025","journal-title":"J. Mater. Chem. B"}],"container-title":["ACS Biomaterials Science &amp; Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsbiomaterials.6c00187","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/7\/3249\/64296452\/ab-2026-00187p.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/7\/3249\/64296452\/ab-2026-00187p.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:09:26Z","timestamp":1791965366000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/abseba\/article\/12\/7\/3249\/5114775\/AI-Driven-Design-and-Clinical-Translation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":84,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,7,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acsbiomaterials.6c00187","relation":{},"ISSN":["2373-9878"],"issn-type":[{"value":"2373-9878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}